Ignite Creation Date:
2024-05-06 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05905055
Status:
RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-03-02
Brief Title:
P3 Study to Assess Efficacy and Safety of CefepimeNacubactam and AztreonamNacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
Sponsor:
Meiji Seika Pharma Co Ltd
Organization:
Meiji Seika Pharma Co Ltd
Organization Data
Organization:
Meiji Seika Pharma Co Ltd
Class:
INDUSTRY
Study ID:
OP0595-6
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Meiji Seika Pharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None